Search clinical trials for: intermediate-2 and high risk myelodysplastic syndromes (MDS)
Total 474764 results
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedMyelodysplastic Syndromes | Secondary Acute Myeloid Leukemia (AML)United States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Helsinn Healthcare SACompletedMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Gastro Intestinal Surgery and Liver Transplantation; The Hepato-Oncology Group...CompletedRadioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaHepatocellular Carcinoma | Liver CancerItaly
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Janssen Research & Development, LLCActive, not recruitingNeoplasms | Myelodysplastic Syndromes | Non-Hodgkin Lymphoma | Solid Tumor, AdultUnited States, Spain, Israel, Germany, Canada
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
Onconova Therapeutics, Inc.Withdrawn
-
M.D. Anderson Cancer CenterGlaxoSmithKlineTerminated
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Montefiore Medical CenterAlbert Einstein College of MedicineWithdrawnMyelodysplastic SyndromesUnited States
-
Peking Union Medical College HospitalUnknownLow/Intermediate Risk-1 MDSChina
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myeloproliferative DiseasesUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Chinese Society of HematologyHarbin Institute of Hematology & OncologyUnknownMyelodysplastic Syndrome (MDS)
-
Eisai Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Peking Union Medical College HospitalNot yet recruiting
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Peking University People's HospitalRecruiting
-
Associazione Qol-oneActive, not recruitingMyelodysplastic Syndromes | ThrombocytopeniaFrance, Germany, Italy, Slovenia
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AmgenCompletedMDSGermany, Italy, Belgium, Czechia, Switzerland, France, Austria, Greece, Spain
-
The First Affiliated Hospital of Soochow UniversityRecruitingAML | MDS | Old Age; Debility | Hematologic CancerChina
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
BioLite, Inc.Not yet recruiting
-
Gesellschaft fur Medizinische Innovation - Hamatologie...AmgenCompletedMyelodysplastic SyndromesFrance, Germany
-
Norwegian University of Science and TechnologyCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
University Of PerugiaRecruitingMDS and Allogeneic Stem Cell TransplantationItaly
-
Apogenix GmbHCompleted
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Zhejiang Provincial Hospital of TCMUnknown
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USACompleted
-
Amphivena Therapeutics, Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
University Hospital, BrestRecruitingMyelodysplastic Syndromes | Chromosome Abnormality | Acute Myeloid Leukemia With Multilineage Dysplasia | Myelodysplastic Syndrome With Ring Sideroblasts | Myelodysplastic Anemia | Myelodysplastic Syndrome With Isolated Del(5Q)France
-
Roxane LaboratoriesCompleted
-
Salzburger LandesklinikenCompletedIntermediate Cervical Plexus Block for Carotid EndarterectomyAustria
-
North-West University, South AfricaMedical Research Council, South Africa; National Research Foundation of South... and other collaboratorsCompletedMalnutrition | Vitamin A Status | Iron Status | Zinc StatusSouth Africa
-
Zogenix MDS, Inc.CompletedThymidine Kinase 2 (TK2)United States, Spain, Israel
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Ortho Biotech Clinical Affairs, L.L.C.Withdrawn
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada